Cargando…

Long-term impact of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight and glycemic control in Japanese type 2 diabetes: an observational study

BACKGROUND: Liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, has been shown to possess pleiotropic effects including body weight reduction. However, long-term effect of liraglutide on body weight and glycemic control has not been elucidated in Japanese type 2 diabetes (T2D) subjects. Present...

Descripción completa

Detalles Bibliográficos
Autores principales:	Inoue, Kana, Maeda, Norikazu, Fujishima, Yuya, Fukuda, Shiro, Nagao, Hirofumi, Yamaoka, Masaya, Hirata, Ayumu, Nishizawa, Hitoshi, Funahashi, Tohru, Shimomura, Iichiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4167135/ https://www.ncbi.nlm.nih.gov/pubmed/25237400 http://dx.doi.org/10.1186/1758-5996-6-95

Ejemplares similares

Efficacy of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight, eating behavior, and glycemic control, in Japanese obese type 2 diabetes
por: Fujishima, Yuya, et al.
Publicado: (2012)

Characteristics of sleep–wake cycle and sleep duration in Japanese type 2 diabetes patients with visceral fat accumulation
por: Fukuda, Shiro, et al.
Publicado: (2017)

Systemic arteriosclerosis and eating behavior in Japanese type 2 diabetic patients with visceral fat accumulation
por: Fukuda, Shiro, et al.
Publicado: (2015)

Significant Association of Serum Adiponectin and Creatine Kinase-MB Levels in ST-Segment Elevation Myocardial Infarction
por: Natsukawa, Tomoaki, et al.
Publicado: (2017)

Short-term effects of liraglutide on visceral fat adiposity, appetite, and food preference: a pilot study of obese Japanese patients with type 2 diabetes
por: Inoue, Kana, et al.
Publicado: (2011)

Impact of visceral fat on gene expression profile in peripheral blood cells in obese Japanese subjects
por: Obata, Yoshinari, et al.
Publicado: (2016)

Low serum eicosapentaenoic acid / arachidonic acid ratio in male subjects with visceral obesity
por: Inoue, Kana, et al.
Publicado: (2013)

Multiple Gouty Tophi with Bone Erosion and Destruction: A Report of an Early-onset Case in an Obese Patient
por: D Hayashi, Reiko, et al.
Publicado: (2017)

A Novel Role for Adipose Ephrin-B1 in Inflammatory Response
por: Mori, Takuya, et al.
Publicado: (2013)

Possible Involvement of Opa-Interacting Protein 5 in Adipose Proliferation and Obesity
por: Inoue, Kana, et al.
Publicado: (2014)

Adipose Hypothermia in Obesity and Its Association with Period Homolog 1, Insulin Sensitivity, and Inflammation in Fat
por: Yamaoka, Masaya, et al.
Publicado: (2014)

Liraglutide is effective in type 2 diabetic patients with sustained endogenous insulin‐secreting capacity
por: Kozawa, Junji, et al.
Publicado: (2012)

High prevalence of gastroesophageal reflux symptoms in type 2 diabetics with hypoadiponectinemia and metabolic syndrome
por: Hirata, Ayumu, et al.
Publicado: (2012)

Low muscle quality in Japanese type 2 diabetic patients with visceral fat accumulation
por: Murai, Jun, et al.
Publicado: (2018)

Ultrastructural Localization of Adiponectin protein in Vasculature of Normal and Atherosclerotic mice
por: Mori, Takuya, et al.
Publicado: (2014)

Adiponectin promotes muscle regeneration through binding to T-cadherin
por: Tanaka, Yoshimitsu, et al.
Publicado: (2019)

Author Correction: Adiponectin promotes muscle regeneration through binding to T-cadherin
por: Tanaka, Yoshimitsu, et al.
Publicado: (2020)

Vascular complications and changes in body mass index in Japanese type 2 diabetic patients with abdominal obesity
por: Nagao, Hirofumi, et al.
Publicado: (2013)

Time-Series Change of Serum Soluble T-Cadherin Concentrations and Its Association with Creatine Kinase-MB Levels in ST-Segment Elevation Myocardial Infarction
por: Iioka, Masahito, et al.
Publicado: (2022)

Adiponectin Protein Exists in Aortic Endothelial Cells
por: Komura, Noriyuki, et al.
Publicado: (2013)

Influence of hepatic impairment on pharmacokinetics of the human GLP-1 analogue, liraglutide
por: Flint, Anne, et al.
Publicado: (2010)

A pilot three-month sitagliptin treatment increases serum adiponectin level in Japanese patients with type 2 diabetes mellitus- a randomized controlled trial START-J study
por: Hibuse, Toshiyuki, et al.
Publicado: (2014)

The Imaging of Insulinomas Using a Radionuclide-Labelled Molecule of the GLP-1 Analogue Liraglutide: A New Application of Liraglutide
por: Lv, Jing, et al.
Publicado: (2014)

Neuroprotection in Rats Following Ischaemia-Reperfusion Injury by GLP-1 Analogues—Liraglutide and Semaglutide
por: Basalay, Maryna V., et al.
Publicado: (2019)

Increased plasma XOR activity induced by NAFLD/NASH and its possible involvement in vascular neointimal proliferation
por: Kawachi, Yusuke, et al.
Publicado: (2021)

Positive correlation between fasting plasma glucagon and serum C-peptide in Japanese patients with diabetes
por: Hosokawa, Yoshiya, et al.
Publicado: (2019)

Identification and Clinical Associations of 3 Forms of Circulating T-cadherin in Human Serum
por: Fukuda, Shiro, et al.
Publicado: (2021)

Adiponectin accumulation in the retinal vascular endothelium and its possible role in preventing early diabetic microvascular damage
por: Sakaue, Taka-aki, et al.
Publicado: (2022)

The Effects of Topiroxostat, a Selective Xanthine Oxidoreductase Inhibitor, on Arterial Stiffness in Hyperuricemic Patients with Liver Dysfunction: A Sub-Analysis of the BEYOND-UA Study
por: Fujishima, Yuya, et al.
Publicado: (2023)

A Japanese patient with a 2p25.3 terminal deletion presented with early‐onset obesity, intellectual disability and diabetes mellitus: A case report
por: Sakaue, Taka‐aki, et al.
Publicado: (2021)

Plasma xanthine oxidoreductase activity in Japanese patients with type 2 diabetes across hospitalized treatment
por: Kawachi, Yusuke, et al.
Publicado: (2020)

Changes in Eating Behaviors and Their Associations with Weight Loss in Japanese Patients Who Underwent Laparoscopic Sleeve Gastrectomy
por: Kimura, Yu, et al.
Publicado: (2023)

A Pilot Investigation of Visceral Fat Adiposity and Gene Expression Profile in Peripheral Blood Cells
por: Yamaoka, Masaya, et al.
Publicado: (2012)

GLP-1 Analogue Liraglutide Attenuates Mutant Huntingtin-Induced Neurotoxicity by Restoration of Neuronal Insulin Signaling
por: Chang, Ching-Chi, et al.
Publicado: (2018)

ER stress decreases exosome production through adiponectin/T-cadherin-dependent and -independent pathways
por: Fukuoka, Keita, et al.
Publicado: (2023)

Clinical significance of visceral fat reduction through health education in preventing atherosclerotic cardiovascular disease - Lesson from the Amagasaki Visceral Fat Study: A Japanese perspective
por: Kishida, Ken, et al.
Publicado: (2011)

Soluble T-cadherin promotes pancreatic β-cell proliferation by upregulating Notch signaling
por: Okita, Tomonori, et al.
Publicado: (2022)

Can glucagon-like peptide-1 (GLP-1) analogues make neuroprotection a reality?
por: Basalay, Maryna V., et al.
Publicado: (2020)

Glucagon, GLP-1 and Thermogenesis
por: González-García, Ismael, et al.
Publicado: (2019)

Chronic Treatment with the GLP1 Analogue Liraglutide Increases Cell Proliferation and Differentiation into Neurons in an AD Mouse Model
por: Parthsarathy, Vadivel, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_2pko8hbe6ee7tgfkcirrpv7e4u